Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Meta-Analysis
. 2019 Apr:99:32-43.
doi: 10.1016/j.jsat.2018.12.003. Epub 2018 Dec 15.

Effectiveness of medication assisted treatment for opioid use in prison and jail settings: A meta-analysis and systematic review

Kelly E Moore  1 , Walter Roberts  2 , Holly H Reid  3 , Kathryn M Z Smith  4 , Lindsay M S Oberleitner  2 , Sherry A McKee  5
Affiliations
Meta-Analysis

Effectiveness of medication assisted treatment for opioid use in prison and jail settings: A meta-analysis and systematic review

Kelly E Moore et al. J Subst Abuse Treat. 2019 Apr.

Abstract

This study examined the state of the literature on the effectiveness of medication assisted treatment (MAT; methadone, buprenorphine, naltrexone) delivered in prisons and jails on community substance use treatment engagement, opioid use, recidivism, and health risk behaviors following release from incarceration. Randomized controlled trials (RCTs) and quasi-experimental studies published through December 2017 that examined induction to or maintenance on methadone (n = 18 studies), buprenorphine (n = 3 studies), or naltrexone (n = 3 studies) in correctional settings were identified from PsycINFO and PubMed databases. There were a sufficient number of methadone RCTs to meta-analyze; there were too few buprenorphine or naltrexone studies. All quasi-experimental studies were systematically reviewed. Data from RCTs involving 807 inmates (treatment n = 407, control n = 400) showed that methadone provided during incarceration increased community treatment engagement (n = 3 studies; OR = 8.69, 95% CI = 2.46; 30.75), reduced illicit opioid use (n = 4 studies; OR = 0.22, 95% CI = 0.15; 0.32) and injection drug use (n = 3 studies; OR = 0.26, 95% CI = 0.12; 0.56), but did not reduce recidivism (n = 4 studies; OR = 0.93, 95% CI = 0.51; 1.68). Data from observational studies of methadone showed consistent findings. Individual review of buprenorphine and naltrexone studies showed these medications were either superior to methadone or to placebo, or were as effective as methadone in reducing illicit opioid use post-release. Results provide the first meta-analytic summary of MATs delivered in correctional settings and support the use of MATs, especially with regard to community substance use treatment engagement and opioid use; additional work is needed to understand the reduction of recidivism and other health risk behaviors.

Keywords: Buprenorphine; Incarceration; Medication assisted treatment; Methadone; Naltrexone.

PubMed Disclaimer

Figures

Figure 1.
Figure 1.
PRISMA Flow Diagram. This figure illustrates how studies were selected for inclusion in this meta-analysis and systematic review.
See this image and copyright information in PMC

References

    1. Andrews D. a., & Bonta J (2010). Rehabilitating criminal justice policy and practice. Psychology, Public Policy, and Law, 16(1), 39–55. 10.1037/a0018362 - DOI
    1. Anne Fullerton C, Meelee Kim M, Cindy Parks Thomas M, Russell Lyman D, Montejano LB, Richard Dougherty CH, … Delphin-Rittmon ME (2014). Assessing the Evidence Base Series Medication-Assisted Treatment With Methadone: Assessing the Evidence. Psychiatric Services, 65, 146–157. 10.1176/appi.ps.201300235 - DOI - PubMed
    1. Aronowitz SV, & Laurent J (2016). Screaming Behind a Door: The Experiences of Individuals Incarcerated Without Medication-Assisted Treatment. Journal of Correctional Health Care, 22(2), 98–108. 10.1177/1078345816634079 - DOI - PubMed
    1. Begg CB, Mazumdar M (1994). Operating characteristics of a rank correlation test for publication bias. Biometrics, 50, 1088–1101. - PubMed
    1. Bellin E, Wesson J, Tomasino V, Nolan J, Glick AJ, Oquendo S (1999). High dose methadone reduces criminal recidivism in opiate addicts. Addiction Research, 7(1), 19–29.

Publication types

MeSH terms